News | March 26, 2009

SenoRX to Market Contura MLB in Europe

March 27, 2009 - SenoRx said this week that it has received the right to apply the CE Mark to its Contura MLB short-term breast radiation balloon catheter.

The multi-lumen radiation balloon delivers radiation to the tissue surrounding a lumpectomy cavity following surgery for breast cancer. The CE Mark applies to both the original size Contura MLB, which is designed for lumpectomy cavities of 4 to 5 centimeters in diameter, as well as the more recently cleared, larger-size Contura Shape Select MLB designed for cavities ranging from 4.5 to 6 cm.

"We believe having the ability to apply the CE Mark to Contura further strengthens our long-term international growth opportunities," said Lloyd Malchow, SenoRx president and CEO. "SenoRx is already marketing its EnCor Breast Biopsy system and GelMark line of tissue markers through local in-country distributors with breast imaging and/or radiology franchises in more than 30 select markets outside the United States. While Contura is currently only being sold in the U.S., we can now begin implementing commercialization plans for the product internationally. We expect to launch Contura in several countries outside the U.S. in 2009 and further expand internationally in a step-wise manner."

For more information: www.senorx.com

Related Content

Insightec Announces Expanded Reach of MR-Guided Focused Ultrasound
News | Focused Ultrasound Therapy | August 22, 2017
Insightec announced recently that worldwide adoption of magnetic resonance (MR)-guided focused ultrasound continues to...
UCLA Study Offers Roadmap to Personalized Therapies for Sarcoma
News | Oncology Diagnostics | August 22, 2017
A new UCLA study is the first to identify patient and tumor characteristics that predict the successful creation of...
Sponsored Content | Videos | Information Technology | August 22, 2017
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of t
Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Overlay Init